Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
Elvira Bangert,1 Laura Wakani,2 Mehveen Merchant,3 Vibeke Strand,4 Zahi Touma2 1Division of Rheumatology, Department of Medicine, Queen’s University, Kingston, ON, Canada; 2University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases,...
Main Authors: | Bangert E, Wakani L, Merchant M, Strand V, Touma Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Patient Related Outcome Measures |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-belimumab-on-patient-reported-outcomes-in-systemic-lupus-ery-peer-reviewed-article-PROM |
Similar Items
-
Belimumab in systemic lupus erythematosus
by: Ankita Srivastava
Published: (2016-01-01) -
EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E. A. Aseeva, et al.
Published: (2015-09-01) -
Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab
by: Guzman M, et al.
Published: (2020-06-01) -
Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management
by: Lou Kawka, et al.
Published: (2021-09-01) -
Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01)